Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Double-blind crossover trial of lamotrigine (Lamictal) as add-on therapy in intractable epilepsy.

Double-blind crossover trial of lamotrigine (Lamictal) as add-on therapy in intractable epilepsy. Epilepsy Res. 1989 Nov-Dec; 4(3):222-9.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.